Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature

Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Soufiane El Hallani, Carole Colin, Younas El Houfi, Ahmed Idbaih, Blandine Boisselier, Yannick Marie, Philippe Ravassard, Marianne Labussière, Karima Mokhtari, Jean-Léon Thomas, Jean-Yves Delattre, Anne Eichmann, Marc Sanson
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Limited 2014-01-01
Saila:BioMed Research International
Sarrera elektronikoa:http://dx.doi.org/10.1155/2014/827327
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak